Apr 30, 2019
The April Journal Club will be discussing the recent paper from the Salk Institute
Posted by Steve Hill in categories: biotech/medical, life extension
The findings, published in the journal Nature Medicine, showcase a novel CRISPR/Cas9 genome-editing therapy that can suppress the accelerated aging observed in mice with Hutchinson-Gilford progeria syndrome. This treatment provides an important insight into the molecular pathways involved in accelerated aging, as well as how to reduce toxic proteins via gene therapy. The researchers hope to translate this therapy to humans to potentially provide a cure for progeria as well as possibly slowing down the aging process to delay the onset of age-related diseases in everyone.
Link to paper: https://www.nature.com/articles/s41591-019-0343-4
Abstract.